ARTICLE | Clinical News
CSI Glucagon regulatory update
December 8, 2014 8:00 AM UTC
FDA and the European Commission granted Orphan Drug designation to CSI Glucagon from Xeris to prevent severe, persistent hypoglycemia related to congenital hyperinsulinism. Xeris plans to submit an IN...